Last: | $10.70 |
---|---|
Change Percent: | 0.19% |
Open: | $10.68 |
Close: | $10.70 |
High: | $10.7 |
Low: | $10.68 |
Volume: | 304,279 |
Last Trade Date Time: | 05/02/2022 04:53:26 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$10.7 | $10.68 | $10.7 | $10.7 | $10.68 | 304,279 | 05-02-2022 |
$10.68 | $10.68 | $10.68 | $10.7 | $10.67 | 897,927 | 04-29-2022 |
$10.68 | $10.68 | $10.68 | $10.7 | $10.68 | 191,906 | 04-28-2022 |
$10.68 | $10.69 | $10.68 | $10.7 | $10.68 | 210,203 | 04-27-2022 |
$10.69 | $10.69 | $10.69 | $10.69 | $10.68 | 228,624 | 04-26-2022 |
$10.69 | $10.68 | $10.69 | $10.69 | $10.67 | 887,759 | 04-25-2022 |
$10.7 | $10.68 | $10.7 | $10.7 | $10.68 | 261,988 | 04-22-2022 |
$10.69 | $10.68 | $10.69 | $10.7 | $10.68 | 216,643 | 04-21-2022 |
$10.69 | $10.68 | $10.69 | $10.7 | $10.68 | 280,275 | 04-20-2022 |
$10.69 | $10.68 | $10.69 | $10.7 | $10.68 | 260,391 | 04-19-2022 |
$10.68 | $10.69 | $10.68 | $10.69 | $10.675 | 275,838 | 04-18-2022 |
$10.69 | $10.68 | $10.69 | $10.69 | $10.67 | 232,966 | 04-15-2022 |
$10.69 | $10.68 | $10.69 | $10.69 | $10.67 | 232,966 | 04-14-2022 |
$10.675 | $10.67 | $10.675 | $10.69 | $10.67 | 135,863 | 04-13-2022 |
$10.67 | $10.68 | $10.67 | $10.69 | $10.67 | 315,254 | 04-12-2022 |
$10.68 | $10.67 | $10.68 | $10.69 | $10.66 | 443,811 | 04-11-2022 |
$10.67 | $10.67 | $10.67 | $10.68 | $10.67 | 227,246 | 04-08-2022 |
$10.67 | $10.67 | $10.67 | $10.7 | $10.67 | 268,522 | 04-07-2022 |
$10.68 | $10.68 | $10.68 | $10.69 | $10.67 | 222,571 | 04-06-2022 |
$10.69 | $10.66 | $10.69 | $10.71 | $10.66 | 706,678 | 04-05-2022 |
News, Short Squeeze, Breakout and More Instantly...
Huttig Building Products Inc. Company Name:
HBP Stock Symbol:
NASDAQ Market:
Huttig Building Products Inc. Website:
--News Direct-- Toronto, Ontario – TheNewswire – December 14, 2023 – Helix BioPharma Corp. (TSX:HBP), (“Helix” or the “Company”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immuno-oncology based o...
(TheNewswire) Toronto, Ontario - TheNewswire - October 27, 2023 - Helix BioPharma Corp. (TSX:HBP) , (“ Helix ” or the “ Company ”), a clinical-stage biopharmaceutical company developing unique therapies in the field of immu...
--News Direct-- Toronto, Ontario - TheNewswire - October 10, 2023 - Helix BioPharma Corp. (TSX:HBP) (“Helix” or the “Company”), an immune-oncology antibody-drug-conjugate company developing an innovative drug platform for the treatment of cancer, announced today th...